medRxiv PreprintsInternational20 November 2026
One blood methylation profile stratifies ten-year risk across 21 common diseases
This is an official announcement record
Firsthand records what medRxiv Preprints announced and links to the original. The wording below is theirs, not ours.
Blood DNA methylation offers a dynamic readout of inherited and acquired influences on health, creating an opportunity for risk prediction beyond polygenic scores, which are fixed at conception and have yet to demonstrate broad clinical utility. As such, we aimed to develop methylation risk scores for 21 common diseases in 12,785 adults from Generation Scotland and the Mass General Brigham Biobank, combining technically reproducible probes, null-calibrated feature selection and ten-year survival models, with evaluation in a single holdout that was not used for feature selection, model fitting
Read the official announcement
Opens www.medrxiv.org
More from medRxiv Preprints
- Unmet needs of Polish patients with cystic fibrosis seen through the lens of crowdfunding20 November 2026
- Motherly Plus: Study Protocol of a Randomized Controlled Trial Evaluating a Smartphone-Assisted Single-Session Psychotherapy Intervention for Postpartum Depression20 November 2026
- Targeting memory consolidation in major depression via pharmacological slow-wave sleep promotion20 November 2026
- Epidemiology of Cardiac Structure and Function Among African Caribbeans in Tobago: A Population-based Cohort Study20 November 2026
- Depressive Symptom Trajectories and Incident Cognitive Impairment by Outcome Ascertainment20 November 2026
This content is for informational purposes only and is not medical advice. It is not intended to diagnose, treat, cure, or prevent any disease. Consult a healthcare professional before starting any supplement, treatment, or program: especially if you are pregnant, nursing, taking medication, or managing a health condition.